Lorigerlimab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Lorigerlimab, covering 2026-02-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 2]